$1.49
0.096.43%
À la fermeture: Nov 24, 4:00 PM EST
$1.52
0.032.01%
Après les heures de négociation: 7:03 PM EST
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Ovid Therapeutics Inc (NASDAQ:OVID) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 3.83M à 3.47M. Cela représente 5.81% des actions disponibles au public de l'entreprise.
Sur la base du volume moyen récent de 1.66M actions échangées par jour, il faudrait 2.09 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
3.47M
Intérêt à court terme %
5.81%
Jours de couverture
2.09
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. Common | 10/31/2025 | 11/11/2025 | 5.81% | 59,643,046 | 3,465,773 | 1,655,192 | 2.09 | |
OVID | Ovid Therapeutics Inc. Common | 10/15/2025 | 10/24/2025 | 6.43% | 59,540,207 | 3,830,348 | 7,847,599 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 09/30/2025 | 10/09/2025 | 1.14% | 59,540,207 | 680,035 | 2,626,824 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 09/15/2025 | 09/24/2025 | 0.82% | 59,540,207 | 488,729 | 1,246,963 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 08/29/2025 | 09/10/2025 | 2.14% | 59,540,207 | 1,274,152 | 1,666,833 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 08/15/2025 | 08/26/2025 | 2.54% | 59,540,207 | 1,511,017 | 1,858,588 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 07/31/2025 | 08/11/2025 | 2.70% | 59,540,207 | 1,610,117 | 3,570,120 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 07/15/2025 | 07/24/2025 | 1.75% | 59,540,207 | 1,044,338 | 972,337 | 1.07 | |
OVID | Ovid Therapeutics Inc. Common | 06/30/2025 | 07/10/2025 | 2.08% | 59,540,207 | 1,240,950 | 2,156,059 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 06/13/2025 | 06/25/2025 | 4.20% | 59,540,207 | 2,498,318 | 1,210,461 | 2.06 | |
OVID | Ovid Therapeutics Inc. Common | 05/30/2025 | 06/10/2025 | 2.79% | 59,540,207 | 1,660,818 | 544,929 | 3.05 | |
OVID | Ovid Therapeutics Inc. Common | 05/15/2025 | 05/27/2025 | 2.74% | 59,540,207 | 1,628,743 | 335,942 | 4.85 | |
OVID | Ovid Therapeutics Inc. Common | 04/30/2025 | 05/09/2025 | 2.29% | 58,591,374 | 1,339,819 | 454,666 | 2.95 | |
OVID | Ovid Therapeutics Inc. Common | 04/15/2025 | 04/25/2025 | 2.05% | 58,591,374 | 1,200,067 | 326,074 | 3.68 | |
OVID | Ovid Therapeutics Inc. Common | 03/31/2025 | 04/09/2025 | 2.07% | 58,591,374 | 1,210,381 | 567,716 | 2.13 | |
OVID | Ovid Therapeutics Inc. Common | 03/14/2025 | 03/25/2025 | 1.82% | 58,591,374 | 1,064,983 | 222,646 | 4.78 | |
OVID | Ovid Therapeutics Inc. Common | 02/28/2025 | 03/11/2025 | 1.72% | 58,526,235 | 1,004,689 | 339,930 | 2.96 | |
OVID | Ovid Therapeutics Inc. Common | 02/14/2025 | 02/26/2025 | 1.69% | 58,526,235 | 991,311 | 410,124 | 2.42 | |
OVID | Ovid Therapeutics Inc. Common | 01/31/2025 | 02/11/2025 | 1.51% | 58,526,235 | 883,735 | 548,841 | 1.61 | |
OVID | Ovid Therapeutics Inc. Common | 01/15/2025 | 01/27/2025 | 1.21% | 58,526,235 | 705,542 | 426,790 | 1.65 | |
OVID | Ovid Therapeutics Inc. Common | 12/31/2024 | 01/10/2025 | 1.18% | 58,526,235 | 692,039 | 357,095 | 1.94 | |
OVID | Ovid Therapeutics Inc. Common | 12/13/2024 | 12/24/2024 | 1.62% | 58,526,235 | 947,754 | 233,254 | 4.06 | |
OVID | Ovid Therapeutics Inc. Common | 11/29/2024 | 12/10/2024 | 1.26% | 58,526,235 | 740,283 | 202,312 | 3.66 | |
OVID | Ovid Therapeutics Inc. Common | 11/15/2024 | 11/26/2024 | 1.29% | 58,526,235 | 756,530 | 307,019 | 2.46 | |
OVID | Ovid Therapeutics Inc. Common | 10/31/2024 | 11/11/2024 | 1.16% | 58,487,946 | 679,890 | 103,906 | 6.54 | |
OVID | Ovid Therapeutics Inc. Common | 10/15/2024 | 10/24/2024 | 1.04% | 58,487,946 | 606,846 | 89,984 | 6.74 | |
OVID | Ovid Therapeutics Inc. Common | 09/30/2024 | 10/09/2024 | 1.08% | 58,487,946 | 633,880 | 149,584 | 4.24 | |
OVID | Ovid Therapeutics Inc. Common | 09/13/2024 | 09/24/2024 | 1.12% | 58,487,946 | 653,891 | 151,347 | 4.32 | |
OVID | Ovid Therapeutics Inc. Common | 08/30/2024 | 09/11/2024 | 1.23% | 58,487,946 | 721,296 | 238,286 | 3.03 | |
OVID | Ovid Therapeutics Inc. Common | 07/31/2024 | 08/09/2024 | 1.83% | 58,460,996 | 1,072,681 | 279,559 | 3.84 | |
OVID | Ovid Therapeutics Inc. Common | 07/15/2024 | 07/24/2024 | 1.88% | 58,460,996 | 1,098,561 | 698,872 | 1.57 | |
OVID | Ovid Therapeutics Inc. Common | 06/28/2024 | 07/10/2024 | 1.76% | 58,460,996 | 1,026,063 | 4,625,295 | 1 | |
OVID | Ovid Therapeutics Inc. Common | 06/14/2024 | 06/26/2024 | 4.90% | 58,460,996 | 2,862,740 | 123,437 | 23.19 | |
OVID | Ovid Therapeutics Inc. Common | 05/31/2024 | 06/11/2024 | 4.91% | 58,460,996 | 2,868,609 | 102,884 | 27.88 | |
OVID | Ovid Therapeutics Inc. Common | 05/15/2024 | 05/24/2024 | 4.88% | 58,460,996 | 2,850,541 | 104,596 | 27.25 | |
OVID | Ovid Therapeutics Inc. Common | 04/30/2024 | 05/09/2024 | 4.84% | 58,327,030 | 2,821,255 | 168,688 | 16.72 | |
OVID | Ovid Therapeutics Inc. Common | 04/15/2024 | 04/24/2024 | 4.80% | 58,327,030 | 2,798,057 | 123,455 | 22.66 | |
OVID | Ovid Therapeutics Inc. Common | 03/28/2024 | 04/09/2024 | 4.84% | 57,915,627 | 2,800,964 | 511,478 | 5.48 | |
OVID | Ovid Therapeutics Inc. Common | 03/15/2024 | 03/26/2024 | 6.33% | 57,915,627 | 3,667,562 | 151,718 | 24.17 | |
OVID | Ovid Therapeutics Inc. Common | 02/29/2024 | 03/11/2024 | 6.31% | 57,915,627 | 3,654,152 | 180,129 | 20.29 | |
OVID | Ovid Therapeutics Inc. Common | 02/15/2024 | 02/27/2024 | 6.21% | 57,886,321 | 3,595,249 | 148,494 | 24.21 | |
OVID | Ovid Therapeutics Inc. Common | 01/31/2024 | 02/09/2024 | 5.77% | 57,886,321 | 3,339,247 | 152,937 | 21.83 | |
OVID | Ovid Therapeutics Inc. Common | 01/12/2024 | 01/24/2024 | 5.31% | 57,886,321 | 3,075,242 | 146,390 | 21.01 | |
OVID | Ovid Therapeutics Inc. Common | 12/29/2023 | 01/10/2024 | 5.01% | 57,886,321 | 2,899,319 | 158,382 | 18.31 | |
OVID | Ovid Therapeutics Inc. Common | 12/15/2023 | 12/27/2023 | 4.28% | 57,886,321 | 2,477,503 | 191,843 | 12.91 | |
OVID | Ovid Therapeutics Inc. Common | 11/30/2023 | 12/11/2023 | 3.97% | 57,886,321 | 2,300,696 | 91,745 | 25.08 | |
OVID | Ovid Therapeutics Inc. Common | 11/15/2023 | 11/27/2023 | 3.70% | 57,886,321 | 2,142,272 | 104,215 | 20.56 |
À la recherche des actions les plus vendues à découvert?